Skip to main content

Astaxanthin Market Size Worth USD 9.21 Billion in 2032 | Emergen Research

Increasing consumer preference for nutraceuticals and preventative medicine, rapid industrialization of the feed industry, rising demand for natural antioxidants and natural cosmetics and awareness about advantages of natural food colors and clean-label products are key factors expected driving astaxanthin market revenue growth.

Vancouver, Dec. 27, 2023 (GLOBE NEWSWIRE) — The global astaxanthin market size was USD 1.94 Billion in 2022 and is expected to register a rapid revenue CAGR of 16.8% during the forecast period. Key drivers include the increasing consumer preference for nutraceuticals, the rapid industrialization of the feed industry, and a rising demand for natural antioxidants and cosmetics. Astaxanthin, a reddish pigment found naturally in some algae, is recognized for its health benefits, including immune system support, inflammation reduction, and cognitive health. The market is further propelled by the growing popularity of yeast/fungi-based and synthetic astaxanthin.

The global astaxanthin market spans various industries, including nutraceuticals, cosmetics, pharmaceuticals, aquaculture & animal feed, and Food & Beverages (F&B). The Natural Algae Astaxanthin Association (NAXA) actively promotes the benefits of natural astaxanthin across diverse applications.

Click to get FREE SAMPLE PDF (Including Full TOC, Table & Figures) @ https://www.emergenresearch.com/request-sample/2603

However, challenges such as strict regulatory standards, high costs, limited R&D activities in developing countries, and potential side effects pose constraints. Recent studies indicating a potential link between high astaxanthin consumption and prostate cancer risk highlight the importance of cautious use.

Source Insights:

In 2022, the natural segment dominated the global astaxanthin market, accounting for the largest revenue share. This is attributed to the antioxidant activity and health advantages of natural astaxanthin, including immune system support and inflammation reduction. The rising demand for natural astaxanthin in nutraceutical applications and its use in cancer treatment contribute to the segment’s growth. Leading market players, such as NextFerm and Beijing Gingko Group, actively engage in developing novel products, expanding applications, and creating new opportunities.

Product Form Insights:

The dried algae meal or biomass segment is anticipated to hold a significant revenue share during the forecast period. This is driven by the advantages of dry astaxanthin, including ease of handling, transport, and usage, as well as extended shelf life. The softgel segment is expected to register the fastest growth due to its stability, wide applicability, and collaborations between market players. For instance, NextFerm and Soft Gel Technologies introduced Astaferm, a novel astaxanthin component designed for softgel applications.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2603

Application Insights:

The aquaculture & animal feed segment is projected to lead in revenue share, supported by the increasing use of astaxanthin as a feed additive in the growing aquaculture industry. In 2023, China is expected to be the world’s largest seafood producer, enhancing the demand for astaxanthin in animal feed. The nutraceuticals segment is expected to grow steadily, driven by the antioxidant capabilities of astaxanthin and its positive impact on cells, free radicals, and oxidative stress.

Regional Insights:

North America claimed the largest revenue share in 2022, attributed to the rising prevalence of nutrient deficiency disorders and new product launches by major market players. Europe secured the second-largest share due to increasing nutrition awareness and regulatory expansions for astaxanthin-rich foods. The Asia Pacific region is poised to register the fastest growth, driven by the rising demand for astaxanthin products, increased R&D spending, and health-conscious consumer preferences.

Scope of Research

Report DetailsOutcome
Market Size in 2022USD 1.94 Billion
CAGR (2023–2032)16.8%
Revenue Forecast To 2032USD 9.21 Billion
Base Year For Estimation2022
Historical Data2019–2021
Forecast Period2023–2032
Quantitative UnitsRevenue in USD Billion and CAGR in % from 2023 to 2032
Report CoverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments CoveredSource, product form, grade, production technology, application, and region
Regional ScopeNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Country ScopeU.S., Canada, Mexico, Germany, France, UK, Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, and Rest of Middle East & Africa
Key Companies ProfiledBASF SE, Divi’s Nutraceuticals, Cyanotech Corporation, DSM Nutritional Products AG, Parry Nutraceuticals., JX Nippon Oil & Gas Exploration Corporation, Fuji Chemical Industries Co., Ltd., Valensa International., Fermenta Biotech Limited, Algalif Iceland ehf., AstaReal Co., Ltd., BGG World, Cardax, Inc., Algatech LTD, Mitacs., Otsuka Pharmaceutical Co., Ltd., INNOBIO Corporation Limited, Sinoway Industrial Co., Ltd., PIVEG, Inc., and FENCHEM
Customization Scope10 hours of free customization and expert consultation

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2603

Major Companies and Competitive Landscape

The global astaxanthin market is fragmented with many medium and large-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing advanced astaxanthin products in the market. Some major players included in the global astaxanthin market report are:

  • BASF SE
  • Divi’s Nutraceuticals
  • Cyanotech Corporation
  • DSM Nutritional Products AG
  • Parry Nutraceuticals
  • JX Nippon Oil & Gas Exploration Corporation
  • Fuji Chemical Industries Co., Ltd.
  • Valensa International.
  • Fermenta Biotech Limited
  • Algalif Iceland ehf
  • AstaReal Co., Ltd.
  • BGG World
  • Cardax, Inc.
  • Algatech LTD
  • Mitacs.
  • Otsuka Pharmaceutical Co., Ltd.
  • INNOBIO Corporation Limited
  • Sinoway Industrial Co., Ltd.
  • PIVEG, Inc.
  • FENCHEM

Strategic Development

  • In May 2022, Divi’s and Algalif combined their expertise to create extremely concentrated beadlets of natural astaxanthin. Divi’s turns this oleoresin into proprietary, easy-to-handle AstaBead beadlets containing 5% astaxanthin – the greatest concentration available – enabling for smaller tablets and hard-shell capsules. AstaBead beadlets also perform well in applications such as nutritional bars.
  • On 5 February 2021, Solabia-Algatech Nutrition launched a range of Astaxanthin Powder Concepts developed for both supplements and beverages. This development provides a versatile and innovative solution to incorporate the potent antioxidant Astaxanthin into a range of consumer products. These powder concepts make it easier to integrate astaxanthi into daily routines.

Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/astaxanthin-market

 Segments Covered in Report

For the purpose of this report, Emergen research has segmented the global astaxanthin market on the basis of source, product form, grade, production technology, application, and region:

  • Source Outlook (Revenue, USD Billion; 2019-2032)
    • Natural
        • Plants
        • Marine Animals
        • Yeast & Microbes
        • Microalgae
  • Product Form Outlook (Revenue, USD Billion; 2019-2032)
    • Dried Algae Meal or Biomass
    • Oil
    • Softgel
    • Liquid
    • Others 
  •  Grade Outlook (Revenue, USD Billion; 2019-2032)
    • Food Grade
    • Cosmetic Grade
    • Feed Grade
  • Production Technology Outlook (Revenue, USD Billion; 2019-2032)
    • Algal Production
    • Fermentation
    • Extraction
    • Chemical Synthesis
  •  Application Outlook (Revenue, USD Billion; 2019-2032)
    • Aquaculture & Animal feed
    • Dietary Supplements
    • Food & Beverages
    • Nutraceuticals
    • Cosmetics
  • Regional Outlook (Revenue, USD Billion; 2019–2032)
    • North America
    • Synthetic
        • U.S.
        • Canada
        • Mexico
    • Europe
        • Germany
        • France
        • UK
        • Italy
        • Spain
        • Benelux
        • Rest of Europe
    • Asia Pacific
        • China
        • India
        • Japan
        • South Korea
        • Rest of APAC
    • Latin America
        • Brazil
        • Rest of LATAM
    • Middle East & Africa
        • Saudi Arabia
        • UAE
        • South Africa
        • Turkey
        • Rest of Middle East & Africa

Curated Reports You Shouldn’t Miss: Dive In Now!

Transradial Access Market, By Product (Catheters, Guidewires, and Others), By Application (Fluid and Nutrition Administration, Drug Administration, and Others), By End-Use, and By Region Forecast to 2032

Reverse Phase Chromatography Resins Market, By Resin Type (Silica-based resins and Polymer based resins), By Particle Size, By Flow Rate, By Format, By End-Use, and By Region Forecast to 2032

Endodontics Market, By Product Type (Instruments and Consumables), By End-Use (Hospitals, Dental Clinics, Research Laboratories, and Others), and By Region Forecast to 2032

Neuroprosthetics Market, By Type (Output Neural Prosthetics and Input Neural Prosthetics), By Technique, By Application, and By Region Forecast to 2032

Synchronous Condenser Market, By Type (New Synchronous Condenser and Refurbished Synchronous Condenser), By Cooling Technology, By Starting Method, By Reacting Power Rating, By End-use, and By Region Forecast to 2032

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.